(2020). The integrin binding peptide, atn-161, as a novel therapy for SARS-CoV-2 infection.
Chicago Style (17th ed.) CitationThe Integrin Binding Peptide, Atn-161, as a Novel Therapy for SARS-CoV-2 Infection. 2020.
MLA (8th ed.) CitationThe Integrin Binding Peptide, Atn-161, as a Novel Therapy for SARS-CoV-2 Infection. 2020.
Warning: These citations may not always be 100% accurate.